Both anti-CD11a (LFA-1) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis (Q71586107)
Jump to navigation
Jump to search
scientific article published on 01 November 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Both anti-CD11a (LFA-1) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis |
scientific article published on 01 November 1995 |
Statements
Both anti-CD11a (LFA-1) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis (English)
E J Gordon
K J Myers
J P Dougherty
H Rosen
1 November 1995